Viewing Study NCT07228832


Ignite Creation Date: 2025-12-24 @ 9:50 PM
Ignite Modification Date: 2026-01-05 @ 5:17 PM
Study NCT ID: NCT07228832
Status: RECRUITING
Last Update Posted: 2025-11-14
First Post: 2025-11-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Sponsor: Summit Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module